ALS Research

Muscular Dystrophy Association Announces nearly $2 Million in Collaborative Research Grants Advancing Treatments Across Multiple Neuromuscular Diseases

December 3, 2025 Comments Off on Muscular Dystrophy Association Announces nearly $2 Million in Collaborative Research Grants Advancing Treatments Across Multiple Neuromuscular Diseases

MDA’s partnership in research includes collaborative research grants with the ALS Network, Cure ADSSL1, Coalition to Cure Calpain 3, Cure CMD, Friedreich’s Ataxia Research Alliance, The Myositis Association, and United…

ALS Network and ALS United Announce New Research Grantees

November 19, 2025 Comments Off on ALS Network and ALS United Announce New Research Grantees

11/20/25 – FOR IMMEDIATE RELEASE LOS ANGELES – The ALS Network, in partnership with 12 ALS United member organizations, announces the selection of its 2025 Research Innovation Grantees—an accomplished group…

Businesswire: The Impossible Dream Machine Partners with Parkland Center for Clinical Innovation (PCCI) to Advance Hope and Innovation in Neurodegenerative Disease Research

November 5, 2025 Comments Off on Businesswire: The Impossible Dream Machine Partners with Parkland Center for Clinical Innovation (PCCI) to Advance Hope and Innovation in Neurodegenerative Disease Research

DALLAS–(BUSINESS WIRE)–The Impossible Dream Machine, an initiative founded by Broadway actor, Grammy-nominated singer, and ALS patient and advocate Aaron Lazar, has announced a groundbreaking collaboration with the Parkland Center for…

AI Accelerates ALS Research

November 4, 2025 Comments Off on AI Accelerates ALS Research

Dr. Steve Finkbeiner and his team at the Gladstone Institutes have developed an AI-powered “thinking microscope” that can independently run experiments, learn from what it observes, and rapidly analyze data — far beyond…

Research Funding Freeze Impacts UCLA

August 12, 2025 Comments Off on Research Funding Freeze Impacts UCLA

The ALS Network is driven by passion — for people, for progress, and for a future without ALS. We partner with world-class researchers, clinicians, and institutions across California and Hawaii…

BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS

October 24, 2023 Comments Off on BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS

–  Resource consumption will be reduced by 50% to accelerate ALS development –  Plans underway for registrational Phase 3b U.S. clinical trial for NurOwn in ALS NEW YORK, Oct. 24,…